Mega Genomics Partners With Onehealth Healthcare in Three-Year Framework Agreement

MT Newswires Live11-09

Mega Genomics (HKG:6667) agreed to provide various services to Meinian Onehealth Healthcare (SHE:002044) under a three-year framework contract between the parties, according to Hong Kong and Shenzhen exchange announcements over the weekend.

Onehealth Healthcare's shares slipped 1% during Monday's afternoon trade.

Under the deal, the services will include testing services, sample collection and analysis, and technical support.

The proposed annual estimates for the services will be up to 475 million yuan in 2027 and will rise to 628.2 million yuan in 2029.

The term will be from Jan. 1, 2027 to Dec. 31, 2029.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment